What is the equity of ASKA Pharmaceutical Holdings Co this year?
ASKA Pharmaceutical Holdings Co has equity of 61.93 B JPY this year.
ASKA Pharmaceutical Holdings Co Equity 2024
ASKA Pharmaceutical Holdings Co Equity
61.93 B JPY
Ticker
4886.T
ISIN
JP3119660003
In 2024, ASKA Pharmaceutical Holdings Co's equity was 61.93 B JPY, a 26.67% increase from the 48.89 B JPY equity in the previous year.
ASKA Pharmaceutical Holdings Co Aktienanalyse
What does ASKA Pharmaceutical Holdings Co do?
ASKA Pharmaceutical Holdings Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing ASKA Pharmaceutical Holdings Co's Equity
ASKA Pharmaceutical Holdings Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding ASKA Pharmaceutical Holdings Co's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating ASKA Pharmaceutical Holdings Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
ASKA Pharmaceutical Holdings Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in ASKA Pharmaceutical Holdings Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about ASKA Pharmaceutical Holdings Co stock
What was the equity of ASKA Pharmaceutical Holdings Co compared to the previous year?
The equity of ASKA Pharmaceutical Holdings Co has increased/decreased by 26.67% increased compared to the previous year.
What impact does a high equity have on investors of ASKA Pharmaceutical Holdings Co?
A high equity is advantageous for investors of ASKA Pharmaceutical Holdings Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of ASKA Pharmaceutical Holdings Co?
A low equity can be a risk for investors of ASKA Pharmaceutical Holdings Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of ASKA Pharmaceutical Holdings Co affect the company?
An increase in equity of ASKA Pharmaceutical Holdings Co can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of ASKA Pharmaceutical Holdings Co affect the company?
A reduction in equity of ASKA Pharmaceutical Holdings Co can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of ASKA Pharmaceutical Holdings Co?
Some factors that can affect the equity of ASKA Pharmaceutical Holdings Co include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of ASKA Pharmaceutical Holdings Co so important for investors?
The equity of ASKA Pharmaceutical Holdings Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can ASKA Pharmaceutical Holdings Co take to change the equity?
To change equity, ASKA Pharmaceutical Holdings Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does ASKA Pharmaceutical Holdings Co pay?
Over the past 12 months, ASKA Pharmaceutical Holdings Co paid a dividend of 45 JPY . This corresponds to a dividend yield of about 2.1 %. For the coming 12 months, ASKA Pharmaceutical Holdings Co is expected to pay a dividend of 48.3 JPY.
What is the dividend yield of ASKA Pharmaceutical Holdings Co?
The current dividend yield of ASKA Pharmaceutical Holdings Co is 2.1 %.
When does ASKA Pharmaceutical Holdings Co pay dividends?
ASKA Pharmaceutical Holdings Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.
How secure is the dividend of ASKA Pharmaceutical Holdings Co?
ASKA Pharmaceutical Holdings Co paid dividends every year for the past 12 years.
What is the dividend of ASKA Pharmaceutical Holdings Co?
For the upcoming 12 months, dividends amounting to 48.3 JPY are expected. This corresponds to a dividend yield of 2.25 %.
In which sector is ASKA Pharmaceutical Holdings Co located?
ASKA Pharmaceutical Holdings Co is assigned to the 'Health' sector.
Wann musste ich die Aktien von ASKA Pharmaceutical Holdings Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of ASKA Pharmaceutical Holdings Co from 12/1/2024 amounting to 25 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.
When did ASKA Pharmaceutical Holdings Co pay the last dividend?
The last dividend was paid out on 12/1/2024.
What was the dividend of ASKA Pharmaceutical Holdings Co in the year 2023?
In the year 2023, ASKA Pharmaceutical Holdings Co distributed 28 JPY as dividends.
In which currency does ASKA Pharmaceutical Holdings Co pay out the dividend?
The dividends of ASKA Pharmaceutical Holdings Co are distributed in JPY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von ASKA Pharmaceutical Holdings Co
Our stock analysis for ASKA Pharmaceutical Holdings Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ASKA Pharmaceutical Holdings Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- ASKA Pharmaceutical Holdings Co Revenue
- ASKA Pharmaceutical Holdings Co Net Income
- ASKA Pharmaceutical Holdings Co P/E
- ASKA Pharmaceutical Holdings Co P/S
- ASKA Pharmaceutical Holdings Co EBIT
- ASKA Pharmaceutical Holdings Co Dividend
- ASKA Pharmaceutical Holdings Co Stocks
- ASKA Pharmaceutical Holdings Co Market capitalization
- ASKA Pharmaceutical Holdings Co Debt
- ASKA Pharmaceutical Holdings Co Liabilities
- ASKA Pharmaceutical Holdings Co Equity
- ASKA Pharmaceutical Holdings Co AAQS
- ASKA Pharmaceutical Holdings Co Employees
- ASKA Pharmaceutical Holdings Co ROE
- ASKA Pharmaceutical Holdings Co ROA
- ASKA Pharmaceutical Holdings Co ROCE